Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (231-240 of 364) with videos related to

Pageof 37
Sort By:
Vaccine|January 23, 2023
Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trialNicholas C Grassly, Nick Andrews, Gillian Cooper, et al.
Pain|March 6, 2020
Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugsVictor Fattori, Noah S Franklin, Rafael Gonzalez-Cano, et al.
International Journal of Medical Informatics|December 28, 2022
Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experienceElise Tessier, Michael Edelstein, Camille Tsang, et al.
British Journal of Pharmacology|July 29, 2025
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?Omar Qureshi, Jamie Cowley, Ashley Pegg, et al.
Nature Communications|July 6, 2023
Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymakingSophie Graham, Elise Tessier, Julia Stowe, et al.
Vaccine|June 29, 2021
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysisFrank Sandmann, Mark Jit, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2020
Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic EvaluationFrank Sandmann, Mark Jit, Nick Andrews, et al.
The Journal of Infectious Diseases|July 5, 2005
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household studyDavid Goldblatt, Mahein Hussain, Nick Andrews, et al.
The Lancet. Infectious Diseases|May 27, 2022
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in EnglandFreja C M Kirsebom, Nick Andrews, Julia Stowe, et al.
Vaccine|August 21, 2007
Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005Mehmet Ceyhan, Inci Yildirim, Paul Balmer, et al.
Pageof 37

Showing results (231-240 of 364) with videos related to

Sort By:
Pageof 37
Vaccine|January 23, 2023
Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trialNicholas C Grassly, Nick Andrews, Gillian Cooper, et al.
Pain|March 6, 2020
Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugsVictor Fattori, Noah S Franklin, Rafael Gonzalez-Cano, et al.
International Journal of Medical Informatics|December 28, 2022
Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experienceElise Tessier, Michael Edelstein, Camille Tsang, et al.
British Journal of Pharmacology|July 29, 2025
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?Omar Qureshi, Jamie Cowley, Ashley Pegg, et al.
Nature Communications|July 6, 2023
Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymakingSophie Graham, Elise Tessier, Julia Stowe, et al.
Vaccine|June 29, 2021
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysisFrank Sandmann, Mark Jit, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2020
Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic EvaluationFrank Sandmann, Mark Jit, Nick Andrews, et al.
The Journal of Infectious Diseases|July 5, 2005
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household studyDavid Goldblatt, Mahein Hussain, Nick Andrews, et al.
The Lancet. Infectious Diseases|May 27, 2022
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in EnglandFreja C M Kirsebom, Nick Andrews, Julia Stowe, et al.
Vaccine|August 21, 2007
Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005Mehmet Ceyhan, Inci Yildirim, Paul Balmer, et al.
Pageof 37